The hemagglutinin-neuramidinase protein of Newcastle disease virus upregulates expression of the TRAIL gene in murine natural killer cells through the activation of Syk and NF-κB
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The hemagglutinin-neuramidinase protein of Newcastle disease virus upregulates expression of the TRAIL gene in murine natural killer cells through the activation of Syk and NF-κB
Authors
Keywords
NK cells, Phosphorylation, Transcription factors, Apoptosis, Newcastle disease virus, Cytotoxicity, Enzyme-linked immunoassays, Interferons
Journal
PLoS One
Volume 12, Issue 6, Pages e0178746
Publisher
Public Library of Science (PLoS)
Online
2017-06-15
DOI
10.1371/journal.pone.0178746
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Enhancement of the Proapoptotic Properties of Newcastle Disease Virus Promotes Tumor Remission in Syngeneic Murine Cancer Models
- (2015) S. Cuadrado-Castano et al. MOLECULAR CANCER THERAPEUTICS
- IPS-1 differentially induces TRAIL, BCL2, BIRC3 and PRKCE in type I interferons-dependent and -independent anticancer activity
- (2015) S Kumar et al. Cell Death & Disease
- Immunomodulatory Effects of Newcastle Disease Virus AF2240 Strain on Human Peripheral Blood Mononuclear Cells
- (2014) Han Yuen Lam et al. International Journal of Medical Sciences
- TRAIL is Involved in the Tumoricidal Activity of Mouse Natural Killer Cells Stimulated by Newcastle Disease Virusin Vitro
- (2013) De-Zhi Song et al. Anatomical Record-Advances in Integrative Anatomy and Evolutionary Biology
- Requirement and Redundancy of the Src Family Kinases Fyn and Lyn in Perforin-Dependent Killing of Cryptococcus neoformans by NK Cells
- (2013) Paul Oykhman et al. INFECTION AND IMMUNITY
- The Oncolytic Activity of Newcastle Disease Virus in Clear Cell Renal Carcinoma Cells in Normoxic and Hypoxic Conditions: The Interplay Between von Hippel-Lindau and Interferon-β Signaling
- (2013) Wei-Choong Ch'ng et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Oncolytic Viruses for Induction of Anti-Tumor Immunity
- (2012) Alex W. Tong et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Differential boosting of innate and adaptive antiviral responses during pegylated-interferon-alpha therapy of chronic hepatitis B
- (2012) Lorenzo Micco et al. JOURNAL OF HEPATOLOGY
- Ethanol promotes cytotoxic effects of tumor necrosis factor-related apoptosis-inducing ligand through induction of reactive oxygen species in prostate cancer cells
- (2012) M K Plante et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Regulation of apoptosis in human melanoma and neuroblastoma cells by statins, sodium arsenite and TRAIL: a role of combined treatment versus monotherapy
- (2011) Vladimir N. Ivanov et al. APOPTOSIS
- Apoptosis Induced by Mammalian Reovirus Is Beta Interferon (IFN) Independent and Enhanced by IFN Regulatory Factor 3- and NF- B-Dependent Expression of Noxa
- (2011) J. J. Knowlton et al. JOURNAL OF VIROLOGY
- Antitumor efficacy of viral therapy using genetically engineered Newcastle disease virus [NDV(F3aa)-GFP] for peritoneally disseminated gastric cancer
- (2010) Kyo Young Song et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Inhibition of Human Natural Killer Cell Activity by Influenza Virions and Hemagglutinin
- (2010) H. Mao et al. JOURNAL OF VIROLOGY
- Genetically engineered Newcastle disease virus for malignant melanoma therapy
- (2009) D Zamarin et al. GENE THERAPY
- Activation of Natural Killer Cells by Newcastle Disease Virus Hemagglutinin-Neuraminidase
- (2009) M. Jarahian et al. JOURNAL OF VIROLOGY
- Efficiency of adjuvant active specific immunization with Newcastle disease virus modified tumor cells in colorectal cancer patients following resection of liver metastases: results of a prospective randomized trial
- (2008) T. Schulze et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Recombinant Newcastle Disease Virus as a Vaccine Vector for Cancer Therapy
- (2008) Adam Vigil et al. MOLECULAR THERAPY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now